WallStSmart
KZR

Kezar Life Sciences Inc

NASDAQ: KZR · HEALTHCARE · BIOTECHNOLOGY

$7.31
+0.14% today

Updated 2026-04-30

Market cap
$53.59M
P/E ratio
P/S ratio
6.03x
EPS (TTM)
$-7.66
Dividend yield
52W range
$4 – $8
Volume
0.1M

Kezar Life Sciences Inc (KZR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-89.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+64.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+9.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+19.7%
2026-03-30
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-30$-1.05+19.6%$6.20$7.42+19.7%
2025-11-12$-1.53-488.5%$6.18$6.15-0.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.31$-1.05+19.6%
2025-09-30$-0.26$-1.53-488.5%
2025-06-30$-0.28$-1.87-567.9%
2025-03-31$-2.65$-2.00+24.5%
2024-12-31$-2.76$-3.00-8.7%$1.04M-119.2%
2024-09-30$-3.15$-2.78+11.7%
2024-06-30$-0.32$-0.27+15.6%
2024-03-31$-0.33$-0.30+9.1%
2023-12-31$-0.38$-0.44-15.8%$-5.43M
2023-09-30$-0.35$-0.32+8.6%$7.00M
2023-06-30$-0.32$-0.34-6.3%
2023-03-31$-0.29$-0.31-6.9%

Frequently asked questions

Has Kezar Life Sciences Inc beaten earnings estimates?
Kezar Life Sciences Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -89.0% over the last 4 quarters.
How does KZR stock react to earnings?
KZR stock has moved an average of +9.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.